Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4233596

O=C(CNCc1ccccc1Br)N(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.40
MEN1 O00255 1/20 0.40
RIPK1 Q13546 1/20 0.39
ALDH1A1 P00352 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
POLQ O75417 1/20 0.36
LMNA P02545 1/20 0.35
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
CYP2C19 P33261 2/20 0.34
SLC6A3 Q01959 2/20 0.34
P2RX7 Q99572 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4233867 0.85 POLQ (0.50) ALDH1A1HTTPOLQEPHX2
Trifluoroacetic Acid SCHEMBL4227420 0.85 ALDH1A1 (0.43) KMT2AMEN1ALDH1A1NPC1RAB9A
Trifluoroacetic Acid SCHEMBL5098273 0.84 TACR1 (0.45) KMT2AALDH1A1NPC1RAB9ANPSR1
Trifluoroacetic Acid SCHEMBL4223287 0.81 HDAC3 (0.43) KMT2AMEN1ALDH1A1NPC1RAB9A
Trifluoroacetic Acid SCHEMBL5108484 0.81 GPR6 (0.39) KMT2AMEN1ALDH1A1NPC1RAB9A
Trifluoroacetic Acid SCHEMBL4235529 0.81 KDM4E (0.50) KMT2AMEN1ALDH1A1POLBLMNA
Trifluoroacetic Acid SCHEMBL4225473 0.79 LMNA (0.45) KMT2AMEN1ALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL4226561 0.74 RAB9A (0.49) KMT2AMEN1ALDH1A1NPC1RAB9A
Trifluoroacetic Acid SCHEMBL4235482 0.72 P2RX7 (0.41) KMT2AMEN1ALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL4236114 0.72 KMT2A (0.48) KMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096104-A1 Organic diamines as mGluR7 modulators Novartis AG (CH) 2009-09-02 EP disclosed
US-20080242698-A1 Organic Compounds NOVARTIS AG (CH) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242698-A1 Organic Compounds AOC1, OTC, ODC1 KMT2A 1438/4885MEN1 464/4885RIPK1 4650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.